Prostatitis is a common disease in adult men, and some data show that approximately 50% of men will be affected by prostatitis at some point in their lives. In China, 8.4% of men aged 15-60 years report prostatitis. The latest typing of prostatitis currently uses the NIH typing method: Type I: acute bacterial prostatitis; Type II: chronic bacterial prostatitis; Type III: over 90% of chronic prostatitis, including subtypes A and B. Type IIIA refers to inflammatory chronic prostatitis (including mycoplasma, chlamydia infection, etc.), and Type IIIB refers to non-inflammatory chronic prostatitis, with A and B accounting for about 50% each; Type IV Type IV refers to asymptomatic prostatitis. Treatment principles: Type I: broad-spectrum antibiotics, with urinary retention fine catheter drainage cargo suprapubic cystocentesis; Type II: oral antibiotics as the main course of treatment for 4-6 weeks, can add alpha-blockers, M-blockers, plant preparations; Type IIIA: can first oral antibiotics for 2-4 weeks, according to the efficacy of the decision to continue to use, can add alpha-blockers, M-blockers, plant preparations, etc.; Type IIIB: with alpha-blockers, M-blockers, plant preparations, etc. Type IIIB: use alpha-blockers, M-blockers, phytochemicals, etc.; Type IV: no treatment is needed. At the same time, attention should be paid to the general treatment of prostatitis, such as health education, psychological and behavioral counseling; patients should abstain from alcohol, avoid being sedentary, etc., and pay attention to strengthening physical exercise.